Suzanne Kamps
About Suzanne Kamps
Suzanne Kamps serves as the Associate Director of Apheresis Operations at Adaptimmune, bringing extensive experience in nursing and apheresis from her previous roles at Children's Hospital of Philadelphia.
Work at Adaptimmune
Suzanne Kamps currently serves as the Associate Director of Apheresis Operations at Adaptimmune, a position she has held since 2021. In this role, she oversees the apheresis operations, ensuring the effective management and execution of procedures related to cell collection and processing. Her expertise contributes to the advancement of Adaptimmune's mission in developing innovative cell therapies.
Education and Expertise
Suzanne Kamps earned her Bachelor of Science (B.S.) degree in Registered Nursing from Drexel University, completing her studies from 2008 to 2012. This educational background laid the foundation for her nursing career, equipping her with the necessary skills and knowledge in patient care and clinical practices, particularly in apheresis.
Background in Nursing
Suzanne Kamps has extensive experience in nursing, particularly in apheresis and oncology. She began her career at the Children's Hospital of Philadelphia, where she worked in various roles, including Apheresis Registered Nurse and Oncology Registered Nurse. Her progression through these positions from 2009 to 2018 provided her with a comprehensive understanding of patient care in specialized units.
Previous Roles at Children's Hospital of Philadelphia
At the Children's Hospital of Philadelphia, Suzanne Kamps held multiple positions that enhanced her expertise in apheresis. She worked as an Apheresis Nurse Extern from 2009 to 2012, later becoming an Apheresis Registered Nurse from 2014 to 2016. Additionally, she served as an Inpatient/Outpatient Registered Nurse Care Coordinator and as an Apheresis Safety-Quality Specialist from 2018 to 2021, focusing on quality and safety in apheresis procedures.
Publications and Contributions
In 2023, Suzanne Kamps participated in an interview published in Cell & Gene Therapy Insights, discussing her experiences and insights related to working with apheresis centers. This contribution highlights her commitment to sharing knowledge and advancing the field of apheresis and cell therapy.